| [1] |
Koizumi M.Nuclear medicine in breast cancer.Jpn J Diagn Imaging,2005,25(10):1257-1263.
|
| [2] |
Bagni B,Franceschetto A,Casolo A,et al.Seintimammography with 99mTc-MIBI and magnetic resonance imaging in the evaluation of breast cancer.Eur J Nuel Med Mol Imaging,2003,30(11):1383-1388.
|
| [3] |
Aursvold JN,Alazraki NP.Updata on detection of sentinel lymph nodes in patients with breast cancer.Semin Nucl Med,2005,35(1):116-128.
|
| [4] |
Koizumi M,Nomura E,Yamada Y,et al.Radioguided sentinel node detection in breast cancer patients:comparion of 99mTc phytate and 99mTc rheninum colloid efficary.Nucl Med Commun,2004,25(9):1031-1034.
|
| [5] |
Veronesi U,Paganellic G,Viale G,et al.A randomized comparion of sentinel-node biopsy with routine axillary dissection in breast cancer.N Engl J Med,2003,349(6):546-553.
|
| [6] |
Kimiihi Uno,Jin Wu,Weijeyko,et al.Diagnostic imaging using FDG-PET in breast cancer.Jpn J Diagn Imaging,2005,25(9):1120-1128.
|
| [7] |
Avri N,Rose CA,Schelling M,et al.Breast imaging with position emission tomography and[fluoro-18]-fluorodeoxyglucose:use and limitation.J Clin Oncol,2000,18(12):3495-3502.
|
| [8] |
Eubank WB,Mankoff DA.Erovling role of position emission tomography in breast cancer imaging.Semin Nucl Med,2005,35(1):84-99.
|
| [9] |
Wahl RL,Siegel BA,Coleman RE,et al.Prospective multicenter study of axillary nodel staging with FDG position emission tomography in breast cancer.J Clin Oncol,2004,22(3):277-285.
|
| [10] |
Suarez M,Petez-castejon MJ,Jimenez A,et al.Early diagnosis of recurrent breast cancer with FDG-PET in patients with progressive elevation of serum tumor markers.Q J Nucl Med,2002,46(1):113-121.
|
| [11] |
Eubank WB,Mankoff DA,Bhattacharya M,et al.Impact of[F-18]-fluorodeoxyglucose PET on defining the extent of disease and mamagement of patients with recurrent or metastatic breast cancer.AJR,2004,183(2):479-486.
|